BR112015022223A2 - composições tópicas e métodos de tratamento de distúrbios tópicos - Google Patents

composições tópicas e métodos de tratamento de distúrbios tópicos

Info

Publication number
BR112015022223A2
BR112015022223A2 BR112015022223A BR112015022223A BR112015022223A2 BR 112015022223 A2 BR112015022223 A2 BR 112015022223A2 BR 112015022223 A BR112015022223 A BR 112015022223A BR 112015022223 A BR112015022223 A BR 112015022223A BR 112015022223 A2 BR112015022223 A2 BR 112015022223A2
Authority
BR
Brazil
Prior art keywords
topical
film
body surface
composition
methods
Prior art date
Application number
BR112015022223A
Other languages
English (en)
Other versions
BR112015022223B1 (pt
Inventor
Eilat Eran
Lozinsky Evgenia
Original Assignee
Peritech Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peritech Pharma Ltd filed Critical Peritech Pharma Ltd
Publication of BR112015022223A2 publication Critical patent/BR112015022223A2/pt
Publication of BR112015022223B1 publication Critical patent/BR112015022223B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Abstract

resumo patente de invenção: "composições tópicas e métodos de tratamento de distúrbios tópicos". a presente invenção refere-se a uma composição tópica que inclui pelo menos um ingrediente formador de filme; pelo menos um tensoativo; pelo menos um solvente de siloxano volátil não polar; pelo menos 15% (p/p) de água; e uma concentração terapeuticamente eficaz de pelo menos um agente farmacêutico, em que a composição é suficientemente projetada para secar em 60 segundos após a aplicação a uma superfície corporal para formar uma composição seca e em que a composição seca forma: um filme flexível, em que o filme flexível segue de perto as irregularidades da superfície corporal bem como o movimento da superfície corporal, e (ii) um filme durável, em que o filme durável não racha ou descama e permanece intacto por mais de 12 horas, proporcionando a liberação do agente farmacêutico por um período de tempo estendido. 1/1
BR112015022223-4A 2013-03-10 2014-03-10 Composição tópica, seu uso, e kit BR112015022223B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361775598P 2013-03-10 2013-03-10
US61/775,598 2013-03-10
IB2014140925 2014-09-18

Publications (2)

Publication Number Publication Date
BR112015022223A2 true BR112015022223A2 (pt) 2017-07-18
BR112015022223B1 BR112015022223B1 (pt) 2022-06-28

Family

ID=51488109

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015022223-4A BR112015022223B1 (pt) 2013-03-10 2014-03-10 Composição tópica, seu uso, e kit

Country Status (12)

Country Link
US (5) US20140255522A1 (pt)
EP (1) EP2968133A4 (pt)
JP (1) JP2016510807A (pt)
KR (1) KR20150136077A (pt)
CN (1) CN105142611B (pt)
AU (1) AU2014229497A1 (pt)
BR (1) BR112015022223B1 (pt)
CA (1) CA2904507C (pt)
IL (1) IL241191B (pt)
MX (1) MX2015012302A (pt)
RU (1) RU2670750C9 (pt)
WO (1) WO2014140925A2 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016510807A (ja) 2013-03-10 2016-04-11 ペリテック・ファーマ・リミテッドＰｅｒｉｔｅｃｈ Ｐｈａｒｍａ Ｌｔｄ． 局所組成物および局所障害の処置方法
EP2994461B1 (en) * 2013-05-10 2021-02-17 M. Alphabet 2, LLC. Methods of treating skin conditions using cyclolignan compounds
US20150366798A1 (en) * 2014-06-19 2015-12-24 Evgenia Lozinsky Pharmaceutical adhesive compositions for treatment of epistaxis and methods of use thereof
AU2015297021A1 (en) * 2014-07-31 2017-03-02 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
WO2016178053A1 (en) * 2015-05-01 2016-11-10 Lozinsky Evgenia Compositions for the treatment of epistaxis
EP3331888A4 (en) * 2015-08-03 2019-03-20 Synergistic Therapeutics, LLC THERAPEUTIC GEL FOR SEXUAL DYSFUNCTION
US20170056332A1 (en) * 2015-08-28 2017-03-02 C.B. Fleet Company, Incorporated Hemorrhoid preparation and sheets
WO2018075071A1 (en) * 2016-10-21 2018-04-26 Wade Hull Pharmaceutical compositions
WO2019064165A1 (en) * 2017-09-28 2019-04-04 Zenvision Pharma Llp SYNERGISTIC PHARMACEUTICAL COMPOSITION OF ACYCLOVIR OR PENCICLOVIR, DOCOSANOL AND HYDROCORTISONE
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
AT521126A2 (de) * 2018-03-29 2019-10-15 Bcsk Biocid Gmbh Sprühpflasterzusammensetzung
AU2020257625A1 (en) 2019-04-17 2021-11-04 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
MX2021015247A (es) 2019-06-14 2022-02-11 Propella Therapeutics Inc Formulaciones topicas de aciclovir y usos de las mismas.
IL291839A (en) 2019-10-01 2022-06-01 Empyrean Neuroscience Inc Genetic engineering of fungi to modulate tryptamine expression
CN110585312A (zh) * 2019-10-18 2019-12-20 北京博达绿洲医药科技研究有限公司 利多去氧乳膏及其制备方法和用途
CN111374938B (zh) * 2020-03-19 2020-12-22 广州杨森药业有限公司 一种含壬二酸的无油凝胶剂及其制备方法
AU2021276656A1 (en) 2020-05-19 2022-11-24 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
CA3085078A1 (en) * 2020-06-29 2021-12-29 Napoleon Savescu Medicament, compound, composition and method for treating herpes
EP4312984A1 (en) * 2021-04-01 2024-02-07 Steel Therapeutics, Inc. Topical wipe containing nifedipine and lidocaine
WO2023172216A1 (en) * 2022-03-11 2023-09-14 Ilko Ilac Sanayi Ve Ticaret A.S. Hydrocortisone and pramoxine topical formulations having enhanced in-vitro release
CN115518031A (zh) * 2022-10-28 2022-12-27 云飞生物药业(吉林)有限公司 一种卡波姆痔疮凝胶

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527224A (en) 1967-09-05 1970-09-08 American Cyanamid Co Method of surgically bonding tissue together
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
IL73534A (en) 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US4613498A (en) 1984-10-24 1986-09-23 Frank Crosby Hemorrhoid medication
US4626433A (en) 1985-05-20 1986-12-02 Preparation Gold, Inc. Remedy for hemorrhoids
US4797392A (en) 1987-01-27 1989-01-10 Chernomorsky Simon A Use of anorectal compositions
US4987893A (en) 1988-10-12 1991-01-29 Rochal Industries, Inc. Conformable bandage and coating material
US5103812A (en) 1988-10-12 1992-04-14 Rochal Industries, Inc. Conformable bandage and coating material
EP0367874B1 (en) 1988-11-08 1992-04-22 Sekisui-Iko Company Ltd. Adhesive applicator
US5756747A (en) 1989-02-27 1998-05-26 Riker Laboratories, Inc. 1H-imidazo 4,5-c!quinolin-4-amines
US5166132A (en) 1989-03-23 1992-11-24 Gordon Arthur L Healing composition employing an enzyme-modified casein
US5219880A (en) 1991-03-29 1993-06-15 Dermatologic Research Corporation Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
US5130124A (en) 1991-05-01 1992-07-14 Isp Investments Inc. Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide
US5234914A (en) 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5627216A (en) 1994-02-07 1997-05-06 Papadopoulos; George D. Medicinal ointment for hemorrhoid and skin care
GB9406854D0 (en) 1994-04-07 1994-06-01 Gillette Co Antiperspirants
US5482936A (en) 1995-01-12 1996-01-09 Minnesota Mining And Manufacturing Company Imidazo[4,5-C]quinoline amines
TW522018B (en) * 1996-05-20 2003-03-01 Shiseido Co Ltd Oil-in-water type emulsified compositions and oil-in-water type emulsifiers containing an Α-monoalkyl glyceryl ether, a wax and a silicone
US6387405B1 (en) 1998-02-27 2002-05-14 E-L Management Corp. Velvety hydrocarbon based cosmetic compositions
EP0966972B1 (en) * 1998-06-18 2003-09-24 Dow Corning France S.A. Topical composition containing silicon gum
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
NZ509618A (en) 1998-08-20 2003-09-26 3M Innovative Properties Co A patch-in-a-bottle that provides a fluid composition, which is applied to a surface and subsequently dries to form a covering, such as a patch
DE60030542T2 (de) 1999-03-25 2007-06-06 3M Innovative Properties Co., Saint Paul Nicht stechendes überzugsmittel
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
GB9913408D0 (en) 1999-06-10 1999-08-11 Albright & Wilson Uk Ltd Personal care formulations
US20020192273A1 (en) 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids
US6833139B1 (en) * 2002-01-09 2004-12-21 Ferndale Laboratories, Inc. Composition and method for the treatment of anorectal disorders
US7879316B2 (en) 2002-06-12 2011-02-01 L'oreal Cosmetic composition containing a polyorganosiloxane polymer
US6821523B2 (en) 2002-06-21 2004-11-23 Dermatrends, Inc. Topical administration of pharmacologically active bases in the treatment of warts
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
ATE375140T1 (de) 2003-01-29 2007-10-15 Unilever Nv Waschmittel
US20040235807A1 (en) 2003-05-21 2004-11-25 Weinrich Karl P. Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea
IL156670A0 (en) 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
DK1680097T3 (da) * 2003-10-27 2009-07-06 Dow Corning Præparater til topisk påföring og fremgangsmåder til afgivelse af et aktivt middel til et substrat
US8022106B2 (en) 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20060004094A1 (en) * 2004-07-02 2006-01-05 Agisim Gary R Composition and method for treating hemorrhoids and/or anorectal disorders
RU2277926C2 (ru) * 2004-07-08 2006-06-20 Общество с ограниченной ответственностью "Медицинское научно-производственное объединение "Биокон" Лекарственная композиция для локального лечения геморроя, трещин анального отверстия и воспалительных заболеваний слизистой оболочки прямой кишки
AU2005262070B2 (en) 2004-07-09 2011-01-27 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US20060105028A1 (en) 2004-11-12 2006-05-18 Jie Zhang Systems and methods for treating warts
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US7318937B2 (en) 2005-03-18 2008-01-15 Closure Medical Corporation Liquid coating compositions
US20070044810A1 (en) 2005-06-29 2007-03-01 Jr Chem, Llc Method of enhanced drug application
WO2007084266A2 (en) 2006-01-19 2007-07-26 Dow Corning Corporation Silicone adhesive for adhesion to wet surfaces
DE102006020382A1 (de) 2006-04-28 2007-10-31 Henkel Kgaa Schnell trocknende kosmetische Emulsionen zur Roll-on-Applikation
US20080014252A1 (en) * 2006-07-14 2008-01-17 Delprete Keith Topical compositions with long lasting effect
WO2008018644A1 (en) 2006-08-09 2008-02-14 Stc Nara Co., Ltd. Cosmetic compositions for improving the performance of transfer-resistant and long-wearing
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US7742730B2 (en) * 2007-10-26 2010-06-22 Xerox Corporation Control to detect air knife blockage
WO2009082511A1 (en) * 2007-12-20 2009-07-02 Elc Management Llc Methods and compositions for treating skin
WO2011003054A2 (en) 2009-07-03 2011-01-06 Dow Corning Corporation Film forming, silicone containing compositions
KR101833959B1 (ko) * 2009-10-23 2018-03-02 다우 코닝 도레이 캄파니 리미티드 오일-기반 원료 물질을 위한 증점제 또는 겔화제
LT2493474T (lt) 2009-10-30 2019-10-10 Intratus, Inc. Būdai ir kompozicijos prolonguotam vaistų įvedimui
US20150231300A1 (en) 2012-10-28 2015-08-20 Peritech Pharma Ltd. Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
JP2016510807A (ja) 2013-03-10 2016-04-11 ペリテック・ファーマ・リミテッドＰｅｒｉｔｅｃｈ Ｐｈａｒｍａ Ｌｔｄ． 局所組成物および局所障害の処置方法
EP2968613B1 (en) 2013-03-11 2019-09-11 University of Florida Research Foundation, Inc. Delivery of card protein as therapy for occular inflammation
US20150366798A1 (en) 2014-06-19 2015-12-24 Evgenia Lozinsky Pharmaceutical adhesive compositions for treatment of epistaxis and methods of use thereof

Also Published As

Publication number Publication date
CA2904507A1 (en) 2014-09-18
CN105142611B (zh) 2019-06-04
US20140256688A1 (en) 2014-09-11
RU2670750C2 (ru) 2018-10-25
US20140255522A1 (en) 2014-09-11
RU2670750C9 (ru) 2018-12-13
CN105142611A (zh) 2015-12-09
US10085995B2 (en) 2018-10-02
BR112015022223B1 (pt) 2022-06-28
EP2968133A4 (en) 2016-03-09
WO2014140925A2 (en) 2014-09-18
WO2014140925A3 (en) 2015-07-30
IL241191B (en) 2020-02-27
US20150272957A1 (en) 2015-10-01
US10085994B2 (en) 2018-10-02
CA2904507C (en) 2021-05-04
US9072747B2 (en) 2015-07-07
IL241191A0 (en) 2015-11-30
US20180344743A1 (en) 2018-12-06
US20140255521A1 (en) 2014-09-11
RU2015143158A3 (pt) 2018-03-20
KR20150136077A (ko) 2015-12-04
AU2014229497A1 (en) 2015-09-24
JP2016510807A (ja) 2016-04-11
MX2015012302A (es) 2016-06-21
RU2015143158A (ru) 2017-04-18
EP2968133A2 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
BR112015022223A2 (pt) composições tópicas e métodos de tratamento de distúrbios tópicos
BR112016011949A8 (pt) composto, composição farmacêutica, e, uso dos mesmos”
BR112014033102A2 (pt) produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido
BR112016014481A2 (pt) tratamento de câncer utilizando combinações de inibidores de erk e raf
BR112015016466A2 (pt) método para o tratamento de câncer baseado no estado de mutação de k-ras
BR112015021352A2 (pt) composições antimicrobianas
BR112015022047A2 (pt) métodos para tratar câncer de bexiga
BR112015018438A2 (pt) anticorpo contra c5 e método para prevenir e tratar doenças relacionadas a complemento
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
BR112013028907A2 (pt) conjugados de proteína-agente ativo e método para preparar os mesmos
DOP2014000260A (es) Compuestos d-aminoácidos para enfermedad hepática
BR112015001847A8 (pt) Composições e tratamento para doenças e distúrbios nos olhos
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
BR112015022545A2 (pt) compostos de pirazolo e os usos disso
BRPI0809164B8 (pt) Composição para administração tópica e composição farmacêutica compreendendo a referida composição
BR112015015870A2 (pt) composição farmacêutica
BR112015024846A2 (pt) composições para utilização no estímulo do crescimento ósseo
RS53598B1 (en) TOPICAL PREPARATIONS FOR THE CONSERVATION OR RE-ESTABLISHMENT OF MALFIN INTEGRITY
BR112016030341A8 (pt) formulação para a remoção não cirúrgica de um depósito de gordura localizada em um indivíduo, método para a remoção não cirúrgica de depósitos de gordura localizada em um indivíduo que tem acúmulo de gordura localizada, e kit
BR112014030279A2 (pt) métodos para tratamento de neutropenia usando agonistas retinóide
CU20150091A7 (es) Estra-1, 3,5(10), 16tetraeno-3-carboxamidas para la inhibición de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
BR112018013227A2 (pt) ?composições farmacêuticas ou kit para o uso, métodos para tratar câncer em um mamífero e uso de uma composição?
BR112015017465A2 (pt) composição de óleo para prevenção de ferrugem
BR112015019264A2 (pt) composições farmacêuticas para o tratamento de helicobacter pylori
BR112012019921A2 (pt) composições líquidas compreendendo um agente de resfriamento não-metol e um espessante para tratamento de um sintoma respiratório.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/03/2014, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 9A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2713 DE 03-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.